ARQT Q4 2021 Earnings — Arcutis Biotherapeutics, Inc. Revenue & Financial Results | Market Cap Arena

ARQTArcutis Biotherapeutics, Inc.

$3B

Q4 2021 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0

Gross Profit

-$211,000

Operating Income

-$71M

Net Income

-$71M

EPS (Diluted)

$-1.42

QoQ Revenue Growth

NaN%

Cash Flow

Operating Cash Flow

-$52M

Free Cash Flow

-$52M

Stock-Based Comp.

$0

Balance Sheet

Total Assets

$408M

Total Liabilities

$110M

Stockholders' Equity

$298M

Cash & Equivalents

$98M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$0	—
Gross Profit	-$211,000	-$166,000	-27.1%
Operating Income	-$71M	-$34M	-109.3%
Net Income	-$71M	-$34M	-109.5%